TCL Archive Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less August 2, 1985
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive High Dose Radiotherapy Plus Chemo Encouraging For Small Cell Lung Cancer November 27, 2009
TCL Archive On Capitol Hill: HCFA Closes Comment Period On Proposal For prospective Payment System That Cancer Groups oppose September 17, 1999
